Invokana (canaglifozin) For Type 2 Diabetes Approved By FDA Sun, 31 Mar, 2013 01:18 AM PDT
The FDA has approved Johnson & Johnson's Invokana (canaglifozin) tablets, to be used with exercise and diet, for adults with type 2 diabetes to improve glycemic control. Type 2 diabetes affects approximately 24 million Americans. Patients eventually tend to have complications from high blood sug...
Continue reading
No comments:
Post a Comment